
11 - 50 employees
Founded 2015
💊 Pharmaceuticals
🧬 Biotechnology
Pharmaceuticals • Biotechnology
Achieve Life Sciences is a late-stage specialty pharmaceutical company focused on developing cytisinicline as a treatment for nicotine dependence (smoking and vaping cessation). The company is advancing cytisinicline through Phase 2 and Phase 3 ORCA trials and has submitted an NDA; its clinical program targets nicotinic receptors to reduce withdrawal and smoking satisfaction, with the goal of providing a new FDA-approved treatment option for tobacco and nicotine dependence.
🕒 July 27
Improve your chances of getting an interview by checking your resume score before you apply.

11 - 50 employees
Founded 2015
💊 Pharmaceuticals
🧬 Biotechnology
Pharmaceuticals • Biotechnology
Achieve Life Sciences is a late-stage specialty pharmaceutical company focused on developing cytisinicline as a treatment for nicotine dependence (smoking and vaping cessation). The company is advancing cytisinicline through Phase 2 and Phase 3 ORCA trials and has submitted an NDA; its clinical program targets nicotinic receptors to reduce withdrawal and smoking satisfaction, with the goal of providing a new FDA-approved treatment option for tobacco and nicotine dependence.
• Developing and leading Achieve Life Sciences’ patient advocacy strategy for cytisinicline, building trusted relationships with patient advocacy organizations, public health coalitions, and community leaders in the nicotine-dependence and tobacco-control space. • Ensuring patient insights and advocacy perspectives are integrated into decision-making across clinical development, market access, and commercialization. • Representing the Company at external advocacy conferences, coalition meetings, and patient-facing events, serving as the primary liaison between Achieve Life Sciences and the patient advocacy community. • Leading the development and execution of Achieve Life Sciences’ public policy strategy, analyzing the federal and state policy environment for tobacco control, nicotine-dependence treatment, and smoking-cessation coverage. • Identifying legislative and regulatory opportunities and risks relevant to cytisinicline, and developing positioning and messaging to advance the Company’s policy priorities. • Ensuring compliance with applicable laws, regulations, and company policies governing lobbying, political activity, and advocacy engagement. • Building and leading the Company’s engagement across lobbyist groups, trade associations, and public health coalitions — including organizations such as the American Lung Association, Truth Initiative, and Campaign for Tobacco-Free Kids — to advance shared policy priorities that support patient access. • Managing relationships with external lobbying firms and consultants, directing lobbying strategy and priorities in alignment with the Company’s commercial and policy objectives. • Cultivating relationships with federal and state policymakers and staff, positioning Achieve Life Sciences as a trusted voice in the nicotine-dependence treatment policy landscape. • Building and leading the patient advocacy and public policy function, recruiting and developing talent to support the Company’s growth.
• Bachelor’s degree in public policy, public health, political science, or a related discipline; an advanced degree (JD, MPH, or MBA) is preferred. • 10+ years of public policy, government affairs, or advocacy experience, including significant experience in the healthcare or biopharmaceutical industry. • Demonstrated success building and leading coalitions across lobbyist groups, trade associations, and patient advocacy organizations, with established relationships in the tobacco-control and public health policy space. • Experience navigating federal and state legislative and regulatory processes relevant to healthcare and tobacco/nicotine policy.
• medical, dental, and vision insurance • a 401(k) retirement plan • participation in the Employee Stock Purchase Plan • company-paid life insurance and short- and long-term disability coverage • paid time off • paid company holidays
Apply Now🕒 July 27
Vice President of Investor Relations at KCSA driving financial communication strategy and team management in a remote setting. Working with B2B communications in cutting-edge industries.
🕒 July 27
VP leading data implementation and calibration for partners in professional sports organizations. Collaborating closely with various teams to ensure efficient and reliable data outputs.
🕒 July 27
VP of Sales driving Strategic and Enterprise sales teams in a B2B SaaS company focused on AI legal technology for law firms.
🇺🇸 United States – Remote
🔥 Funding within the last year
💰 $103M Series B - Eve on 2025-09
⏰ Full Time
🔴 Lead
👔 Vice President
🕒 July 27
Vice President leading data and analytics products for OptimizeRx. Responsible for product strategy, development, and commercialization in healthcare solutions.
🇺🇸 United States – Remote
💵 $200k - $220k / year
💰 $9M Post-IPO Equity - OPTIMIZERx on 2018-05
⏰ Full Time
🔴 Lead
👔 Vice President
🕒 July 27
VP of Translational Sciences managing the strategy and execution of oncology drug development. Leading translational framework and regulatory readiness for clinical trials at Shasqi.
🇺🇸 United States – Remote
💵 $300k - $325k / year
💰 $1.9M Grant on 2022-01
⏰ Full Time
🔴 Lead
👔 Vice President